MORGAN STANLEY PLC/PUT/ABBOTT LABORATORIES/100/0.1/19.12.25 Stock

Warrant

DE000ME18ED0

Market Closed - Börse Stuttgart 14:49:27 2024-07-05 EDT
0.76 EUR -1.30% Intraday chart for MORGAN STANLEY PLC/PUT/ABBOTT LABORATORIES/100/0.1/19.12.25
Current month+4.11%
3 months+10.14%
Date Price Change
24-07-05 0.76 -1.30%
24-07-04 0.77 -1.28%
24-07-03 0.78 +2.63%
24-07-02 0.76 -2.56%
24-07-01 0.78 +6.85%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 02:49 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN ME18ED
ISINDE000ME18ED0
Date issued 2023-09-27
Strike 100 $
Maturity 2025-12-19 (531 Days)
Parity 10 : 1
Emission price 1.29
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.6
Lowest since issue 0.49
Spread 0.01
Spread %1.32%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104 USD
Average target price
124.9 USD
Spread / Average Target
+20.09%
Consensus